BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10372835)

  • 1. Vitamin D and the parathyroid.
    Beckerman P; Silver J
    Am J Med Sci; 1999 Jun; 317(6):363-9. PubMed ID: 10372835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
    Buchwald PC; Westin G; Akerström G
    Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
    Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
    Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.
    Sela-Brown A; Russell J; Koszewski NJ; Michalak M; Naveh-Many T; Silver J
    Mol Endocrinol; 1998 Aug; 12(8):1193-200. PubMed ID: 9717845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.
    Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ
    Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor genotypes in primary hyperparathyroidism.
    Carling T; Kindmark A; Hellman P; Lundgren E; Ljunghall S; Rastad J; Akerström G; Melhus H
    Nat Med; 1995 Dec; 1(12):1309-11. PubMed ID: 7489414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
    Carling T; Rastad J; Szabó E; Westin G; Akerström G
    J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor and analogs.
    Dusso AS; Thadhani R; Slatopolsky E
    Semin Nephrol; 2004 Jan; 24(1):10-6. PubMed ID: 14730505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium, phosphate, vitamin D, and the parathyroid.
    Marks KH; Kilav R; Naveh-Many T; Silver J
    Pediatr Nephrol; 1996 Jun; 10(3):364-7. PubMed ID: 8792407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of parathyroid hormone synthesis in chronic renal failure in rats.
    Fukagawa M; Kaname S; Igarashi T; Ogata E; Kurokawa K
    Kidney Int; 1991 May; 39(5):874-81. PubMed ID: 2067203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
    Slatopolsky E; Finch J; Ritter C; Takahashi F
    Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vitamin D analogs.
    Slatopolsky E; Finch J; Brown A
    Kidney Int Suppl; 2003 Jun; (85):S83-7. PubMed ID: 12753273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells.
    Brown AJ; Ritter CS; Knutson JC; Strugnell SA
    Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of phosphorus in the development of secondary hyperparathyroidism and parathyroid cell proliferation in chronic renal failure.
    Slatopolsky E; Dusso A; Brown AJ
    Am J Med Sci; 1999 Jun; 317(6):370-6. PubMed ID: 10372836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
    Korkor AB
    N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of parathyroid cell proliferation.
    Silver J; Sela SB; Naveh-Many T
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):321-6. PubMed ID: 9263680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease.
    Silver J; Levi R
    Kidney Int Suppl; 2005 Jun; (95):S8-12. PubMed ID: 15882315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.